You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Type 2 Diabetes Mellitus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Circulatory Disorder Due to Type 2 Diabetes Trial (Buerger-Allen Exercise)

Not yet recruiting
  • Peripheral Circulatory Disorder Due to Type 2 Diabetes Mellitus
  • Buerger-Allen Exercise
  • (no location specified)
Sep 26, 2023

Pre-Existing Type 2 Diabetes Trial in Afyonkarahisar (Education)

Completed
  • Pre-Existing Type 2 Diabetes Mellitus
  • Education
  • Afyonkarahisar, Turkey
    Afyonkarahisar Health Sciences University
Aug 1, 2023

Diabetes, Type 2 Trial (FoodSwitch)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • FoodSwitch
  • (no location specified)
Jul 28, 2023

Serum Magnesium Level in Type 2 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus
  • Magnesium
  • Sohag, Egypt
    Sohag university Hospital
Sep 22, 2023

Electrolyte Disorders in Prediabetics and in Type 2 Diabetes

Not yet recruiting
  • Type 2 Diabetes Mellitus and Electrolyte Disorders
    • (no location specified)
    Apr 2, 2023

    Diabetes, Type 2 Trial in Tanta, Shibin Al Kawm (Nitazoxanide)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Tanta, El-Gharbia, Egypt
    • +1 more
    Aug 21, 2023

    Blood Metabolic Markers in Type 2 Diabetes Mellitus of Different

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • No intervention
    • Jinan, Shandong, China
      Peng Wu
    Nov 24, 2023

    Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Multiple Dose Insulin Therapy
    • Personalized treatment
    • (no location specified)
    Nov 18, 2023

    Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • SGLT2 inhibitor
    • Seoul, Seodaemun-gu, Korea, Republic of
      Severance Hospital
    Nov 17, 2023

    T2DM (Type 2 Diabetes) Trial (DWP16001 0.3 mg)

    Not yet recruiting
    • T2DM (Type 2 Diabetes Mellitus)
    • DWP16001 0.3 mg
    • (no location specified)
    Nov 15, 2023

    Type 2 Diabetes Trial in Kansas City (Intermittent energy restriction (IER), Time Restricted Eating (TRE))

    Recruiting
    • Type 2 Diabetes
    • Intermittent energy restriction (IER)
    • Time Restricted Eating (TRE)
    • Kansas City, Kansas
      University of Kansas Medical Center
    May 5, 2023

    Width and HbA1C in Type 2 Diabetes Mellitus After Glycemic

    Not yet recruiting
    • Type 2 Diabetes
    • Glycated hemoglobin (HbA1C)
    • +2 more
    • (no location specified)
    Sep 28, 2023

    Blood Glucose Variability in Type 2 Diabetes Mellitus and

    Recruiting
    • COVID-19 Pneumonia
    • Type2diabetes
    • Glucose variability
    • Jinan, Shandong, China
      Qilu hospital of shandong university
    Nov 24, 2023

    Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty

    Completed
    • Type 2 Diabetes Mellitus
    • +2 more
    • omega-3 polyunsaturated fatty acids
    • corn oil
    • Lianshui, Jiangsu, China
      Lian Shui People's Hospital
    Oct 2, 2023

    Peripheral Protective Sensation in Type 2 Diabetes Mellitus

    Not yet recruiting
    • Diabetic Foot
    • Diabetic Neuropathies
    • Foot Sole Sensation Evaluation
    • (no location specified)
    Jun 6, 2023

    Dapagliflozin in Type 2 Diabetes Mellitus and Hypertension

    Not yet recruiting
    • Diabetes Mellitus
    • Hypertension
      • Incheon, Namdong-gu, Korea, Republic of
        Gachon University Gil Medical Center
      Jul 24, 2023

      Diabetes, Type 2 Trial in Tanta, Shibin Al Kawm (Ursodeoxycholic acid)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Ursodeoxycholic acid
      • Tanta, El-Gharbia, Egypt
      • +1 more
      Jun 5, 2023

      Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

      Not yet recruiting
      • Fatty Liver, Nonalcoholic
      • SGLT2 inhibitor
      • (no location specified)
      Oct 31, 2023

      Healthy, Type 2 Diabetes Trial in United States (LY3938577, Placebo, Insulin degludec)

      Not yet recruiting
      • Healthy
      • Type 2 Diabetes Mellitus
      • Anaheim, California
      • +3 more
      Nov 10, 2023

      Type 2 Diabetes Trial in Beijing, Shijiazhuang (HEC88473, Placebo, Dulaglutide)

      Recruiting
      • Type 2 Diabetes
      • HEC88473, Placebo, Dulaglutide
      • Beijing, Beijing, China
      • +1 more
      Nov 20, 2023

      Diabetes, Type 2, Heart Failure Preserved Ejection Fraction Trial in Lumezzane (Evaluation of central and peripheral

      Recruiting
      • Diabetes Mellitus, Type 2
      • Heart Failure Preserved Ejection Fraction
      • Evaluation of central and peripheral neuromuscular fatigue
      • Lumezzane, Brescia, Italy
        Istituti Clinici Scientifici Maugeri IRCCS
      Sep 21, 2023

      Type 2 Diabetes (T2DM) Trial in Nanjing (Endovascular denervation System (Generator and Catheter ))

      Recruiting
      • Type 2 Diabetes Mellitus (T2DM)
      • Endovascular denervation System (Generator and Catheter )
      • Nanjing, Jiangsu, China
        Zhongda Hospital, Southeast University
      Jan 2, 2023

      Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)

      Completed
      • Type 2 Diabetes Mellitus
      • HSK7653 10 mg
      • +3 more
      • Beijing, Beijing, China
        Peking university people's hospital
      Sep 23, 2023

      Diabetic Patients, Type II Diabetes Trial in Sevilla (OA-enriched functional olive oil, commercial olive oil)

      Recruiting
      • Diabetic Patients
      • Type II Diabetes Mellitus
      • OA-enriched functional olive oil
      • commercial olive oil
      • Sevilla, Andalicía, Spain
        Virgen del Rocío University Hospital
      Sep 1, 2023

      Type 2 Diabetes Trial (HRS-7535, Placebo)

      Not yet recruiting
      • Type 2 Diabetes
      • (no location specified)
      Feb 26, 2023